Search Results - "Metin Cakar, N."

736 Demographic and anthropometric changes and the relationship between variables and survival analysis of people with cystic fibrosis by years by Karabulut, S., Kalyoncu, M., Balci, M. Selcuk, Cakar, N. Metin, Yıldız, C., Uzunoğlu, B., Tastan, G., Ergenekon, A., Eralp, E. Erdem, Gokdemir, Y., Karakoc, F., Karadag, B.

Get full text

383 Assessing cystic fibrosis regulatory modulators: a comprehensive retrospective analysis on patient subgroups and clinical outcomes by Yıldız, C., Kalyoncu, M., Balci, M. Selcuk, Karabulut, S., Cakar, N. Metin, Uzunoğlu, B., Tastan, G., Ergenekon, A., Eralp, E. Erdem, Gokdemir, Y., Karakoç, F., Karadağ, B.

Get full text

P140 This abstract is a study that investigates demographic and anthropometric changes, the relationship between variables and survival analyses of people with cystic fibrosis by years by Karabulut, S., Kalyoncu, M., Selcuk, M., Metin Cakar, N., Yıldız, C.A., Uzunoglu, B., Tastan, G., Ergenekon, A.P., Erdem Eralp, E., Gokdemir, Y., Karakoc, F., Karadag, B.

Get full text

P028 This study assesses cystic fibrosis regulatory modulators through a comprehensive retrospective analysis on patient subgroups and clinical outcomes by Yıldız, C.A., Kalyoncu, M., Selcuk Balcı, M., Karabulut, Ş., Metin Cakar, N., Ergenekon, A.P., Erdem Eralp, E., Gokdemir, Y., Karakoc, F., Karadağ, B.

Get full text

P114 Social determinants of health in cystic fibrosis by Metin Cakar, N., Kalyoncu, M., Selcuk, M., Karabulut, S., Yildiz, C.A., Uzunoglu, B., Tastan, G., Kocaman, D., Ergenekon, A.P., Gokdemir, Y., Erdem Eralp, E., Karakoc, F., Karadag, B.

Get full text

P254 Clinical effects of Achromobacter xylosoxidans in patients with cystic fibrosis by Karabulut, S., Yanaz, M., Gulieva, A., Kalyoncu, M., Selcuk, M., Cakar, N. Metin, Demirkol, E., Ergenekon, A.P., Eralp, E.E., Gokdemir, Y., Karakoc, F., Karahasan, A., Karadag, B.

Get full text

P119 Exploring the attitudes and knowledge of the caregivers of children with cystic fibrosis and primary ciliary dyskinesia regarding COVID-19 vaccination by Ergenekon, A.P., Karabulut, S., Yilmaz Yegit, C., Yanaz, M., Gulieva, A., Kalyoncu, M., Selcuk, M., Metin Cakar, N., Uzunoglu, B., Tastan, G., Eralp, E.E., Gokdemir, Y., Karadag, B.

Get full text

645 Screening for food insecurity in individuals with cystic fibrosis by Kocaman, D., Cakar, N. Metin, Uzunoğlu, B., Tastan, G., Kalyoncu, M., Balci, M. Selcuk, Karabulut, S., Yıldız, C., Ergenekon, A., Gokdemir, Y., Eralp, E. Erdem, Karakoç, F., Karadağ, B.

Get full text

472 Social determinants of health in people with cystic fibrosis in a low resource setting by Cakar, N. Metin, Karabulut, S., Kalyoncu, M., Balci, M. Selcuk, Yıldız, C., Kocaman, D., Uzunoğlu, B., Tastan, G., Ergenekon, A., Eralp, E. Erdem, Gokdemir, Y., Karakoc, F., Karadag, B.

Get full text

336 Comparison of mental health status in people with CF who are eligible and ineligible and lack access to elexacaftor/tezacaftor/ivacaftor by Balci, M. Selcuk, Uzunoğlu, B., Kalyoncu, M., Karabulut, S., Cakar, N. Metin, Yıldız, C., Kocaman, D., Tastan, G., Ergenekon, A., Gokdemir, Y., Eralp, E. Erdem, Karakoç, F., Karadağ, B.

Get full text

P378 Comparison of anxiety and depression levels in cystic fibrosis patients with and without modulatory therapy by Uzunoglu, B., Selcuk Balci, M., Kalyoncu, M., Karabulut, S., Metin Cakar, N., Yildiz, A.C., Kocaman, D., Tastan, G., Ergenekon, A.P., Gokdemir, Y., Erdem Eralp, E., Karakoc, F., Karadag, B.T.

Get full text

P334 Screening for food insecurity in individuals with cystic fibrosis by Kocaman, D., Metin Cakar, N., Uzunoglu, B., Tastan, G., Kalyoncu, M., Selcuk Balci, M., Karabulut, S., Yildiz, A.C., Ergenekon, A.P., Gokdemir, Y., Erdem Eralp, E., Karakoc, F., Karadag, B.

Get full text

422 Outcomes of patients with intermittent versus continuous access to CFTR modulator therapy in Turkey by Ergenekon, A., Yanaz, M. Cenk, Guliyeva, A., Yuksel, M., Selçuk, M., Karabulut, S., Cakar, N. Metin, Uzunoglu, B., Tastan, G., Kocamaz, D., Phan, H., Gokdemir, Y., Eralp, E. Erdem, Nasr, S., Karakoc, F., Karadag, B.

Get full text

435 Outcomes of cessation of CFTR modulator therapy: an unfortunate experience by Ergenekon, A., Yanaz, M. Cenk, Guliyeva, A., Yuksel, M., Selçuk, M., Karabulut, S., Cakar, N. Metin, Uzunoglu, B., Tastan, G., Kocamaz, D., Phan, H., Gokdemir, Y., Eralp, E. Erdem, Nasr, S., Karakoc, F., Karadag, B.

Get full text

P409 Increased knowledge levels of cystic fibrosis patients following implementation of a standard and modified CF R.I.S.E programme in a limited resource country by Selçuk Balcı, M., Gokdemir, Y., Erdem Eralp, E., Ergenekon, A.P., Yilmaz Yegit, C., Yanaz, M., Gulieva, A., Kalyoncu, M., Karabulut, S., Metin Cakar, N., Uzunoglu, B., Tastan, G., Kocaman, D., Kenis Coskun, O., Gorgun, I., Messier, R., Mertz, P., Karakoc, F., Karadag, B.

Get full text

640 Cystic fibrosis transition program (CF RISE) translated to Turkish (KF SOBE): first annual results by Gokdemir, Y., Selçuk, M., Eralp, E. Erdem, Ergenekon, A., Yegit, C. Yilmaz, Yanaz, M. Cenk, Guliyeva, A., Kalyoncu, M., Karabulut, S., Uzunoglu, B., Tastan, G., Kocamaz, D., Cakar, N. Metin, Kenis-Coskun, O., Gorgun, I., Messier, R., Merz, P., Karakoc, F., Karadag, B.

Get full text

P027This study presents a comprehensive genetic and clinical profiling of patients with cystic fibrosis ineligible for CFTR modulator therapy, offering insights from a diverse patient cohort by Yıldız, C.A., Kalyoncu, M., Selçuk Balcı, M., Karabulut, Ş., Metin Çakar, N., Başer, Z.M., Ergenekon, A.P., Erdem Eralp, E., Gökdemir, Y., Ata, P., Karakoç, F., Karadağ, B.

Get full text

P407 Is it possible to increase parental knowledge about cystic fibrosis through education? by Kalyoncu, M., Metin Çakar, N., Arslan, H., Can Oksay, S., Selçuk Balcı, M., Karabulut, S., Yıldız, C.A., Kılıc Başkan, A., Uzunoğlu, B., Tastan, G., Ergenekon, P., Girit, S., Kılınç Sakallı, A., Cokuğraş, H., Çakır, E., Erdem Eralp, E., Gökdemir, Y., Karakoç, F., Karadağ, B.

Get full text